Navigation Links
ADAMS Welcomes Debbie Aiken and Brandon Cannaday to the Firm's Staff as Associate Project Managers
Date:3/5/2008

ied potential clients for lawsuits and assisted in the training and mentoring of newly hired paralegals. Mr. Cannaday holds a Bachelor of Arts in Economics from Colgate University in Hamilton, New York.

In their new roles as Associate Project Managers at ADAMS, Ms. Aiken and Mr. Cannaday have primary responsibility for developing, distributing and managing project documentation; developing reports to inform and update client leadership; managing issues to resolution; and assisting senior project management staff in updating master program budgets and schedules. Both professionals are currently involved in a management program titled Vision 2010 for University Hospitals in Cleveland, Ohio. The focus of the capital program is to grow and improve the delivery of healthcare to the greater Cleveland area, with a target completion date of 2010.

Photo of Debbie Aiken: http://www.ereleases.com/pr/2008-ADAMSAiken.jpg

Photo of Brandon Cannaday: http://www.ereleases.com/pr/2008-ADAMSCannaday.jpg

More About ADAMS

ADAMS is an independent, objective consulting and program management firm exclusively focused on capital project planning and delivery for healthcare systems and the health sciences since 1986. From offices in Atlanta, Baltimore, Birmingham, Cleveland, Dallas, Denver, Los Angeles, New Orleans and Phoenix, the firm currently represents its national client base in over $5 billion of healthcare and research facility development programs. For more information about ADAMS, please visit our website at http://www.adamspmc.com.

For additional information, contact:

Alana Cobb

Associate Director - Marketing & Public Relations

ADAMS

404.304.2166

acobb@ada
'/>"/>

SOURCE ADAMS Management Services Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
2. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
3. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
4. LeMaitre Vascular to Participate at Canaccord Adams Inaugural Cardiovascular Conference
5. Reckitt Benckiser Commences Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics
6. America Selects Earlham Resident Marilyn Adams as One of the Nations Top Hometown Heroes
7. Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
8. ADAMS Performs Management Services for University Hospitals $600 Million Expansion/Renovation Program in Cleveland, OH
9. ADAMS Announces the Addition of Dani Barfield to the Firms Staff as Associate Project Manager
10. Womens World Banking Welcomes New Network Member From Tunisia
11. MJGC Welcomes New Administrator-in-Training Shlomo Katz

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Nov. 27 Preventing dis... fortunately every year, new vaccines are being ad...ccines boost immunity for the same period of time?...needed to keep immunity strong? ,, In this mo...ican Academy of Pediatrics, Michael Pichichero MD,...
(Date:11/27/2009)...-emission vehicles may reduce future disease burde...HealthDay News) -- Encouraging city dwellers to wa...uch greater public health benefits than increased ...ve found. , The study compared the projected he...nsport scenarios for London, England, and Delhi, I...
(Date:11/27/2009)...lti-purpose bilingual coloring books designed for ...iness community to educate - inform parents and ch...issues to Dinosuars to ABC,S and a host of other t...(PRWEB) November 27, 2009 -- Today’s childre... them busy any hour of the day, but one of the old...
(Date:11/26/2009)...., Nov. 27 The diabetes population...next 25 years and annual medical spending on the d...113 billion today, according to a study published ...ional Changing Diabetes ® Program (NCDP), a ... by a team from the University of Chicago. ,, A...
(Date:11/26/2009)...n on an emotional rollercoaster, study finds , ...l it the fear factor meets the jubilant sports fan...ecially those who root for the winning team -- enj...tested match and victory was in doubt, producing f...at this Thanksgiving weekend as you,re glued to th...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...eilman Center,electro-mechanical manufacturing pla... a 2007 IndustryWeek magazine "Best Plant Finalist...e on the leading edge of efforts to,increase compe...09/MEDRADLOGO ) MEDRAD,s Heilman Center plant wa...
... patients, side effects impacting cognition don,t ...ng to a new survey, the cognitive impairment exper...be long-lasting and severely affect their personal...nize or multi-task have led to significant problem...
...7 The first significant genetic finding in premen...rted. PMDD is a very severe form of the more comm... heritable, affects 5-8% of women, and is associat... that quality of life is seriously impacted. Prev...
...Sales of World,s First Pocket Ultrasound ...if., Oct. 2 Siemens Medical,Solutions (http://ww...of medicine,with today,s launch of the world,s sma...1.6 pounds, and fits easily,into a lab coat pocket...
...imax GmbH, Campbell,CA, is pleased to announce tha...nc. the company is moving to larger premises in No...d. As of October 1st, 2007,joimax, Inc. will be lo...Michael Stek, CEO of the joimax, Inc. "Due to the ...
... Phylonix Pharmaceuticals, Inc. today announced t...l Business Innovation Grant (SBIR) from the Nation...lth (NIH) to develop zebrafish eye disease models ...onserved organ and the basic structure between hum...
Other Medicine News:Health News:MEDRAD Plant Named IndustryWeek Magazine Award Finalist 2Health News:MEDRAD Plant Named IndustryWeek Magazine Award Finalist 3Health News:Cognitive deficits lead to 'loss of self' among cancer patients 2Health News:First significant genetic finding in severe PMS, or PMDD 2Health News:Good Imaging Now Comes in the World's Smallest Ultrasound Package 2Health News:Good Imaging Now Comes in the World's Smallest Ultrasound Package 3Health News:NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases 2
(Date:11/25/2009)..., WESTON, Fla., Nov. 25 /PRNewswire-FirstCall/ -... ASFX) ("the Company") is pleased to announce that...ion management office in Shanghai, China. ,, AS...ding an essential gateway for the development and ... products for children and adults to be distribute...
(Date:11/25/2009)...RINCETON, N.J., Nov. 25 ...e pharmaceutical company committed to discovering,...at viral infections, reported financial results fo...tember 30, 2009 Pharmasset held $58.4 million in c... ,, Pipeline Update and 2009 Highlights ,,...
(Date:11/25/2009)...XTON, Pa., Nov. 25 BioTrends Resea...nds(TM) : Stelara report, the first in a mult...g the launch of Centocor Ortho-Biotech,s Stelara, ...f availability. Each wave of the report provides ...ists and qualitative information from a subset of ...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Iowa Drug Card a Huge Success With Iowans 55345 1Iowa Drug Card a Huge Success With Iowans 55345 2VA Chiefs Vow to The American Legion 3A We Will End Vet Homelessness 55343 1VA Chiefs Vow to The American Legion 3A We Will End Vet Homelessness 55343 2Mayo Clinic Proceedings 3A Common Blood Disorder May Not be Linked to as Many Serious Diseases as Previously Thought 55341 1Mayo Clinic Proceedings 3A Common Blood Disorder May Not be Linked to as Many Serious Diseases as Previously Thought 55341 2Mayo Clinic Proceedings 3A Common Blood Disorder May Not be Linked to as Many Serious Diseases as Previously Thought 55341 3
... out of ten patients taking,once-daily Lialda rema...TON, D.C., May 22, 2007 /PRNewswire-FirstCall/ -- ...nsion study (303),presented at the British Society...tland in March 2007 showed Shire plc,s,Lialda(mesa...atients. Today, secondary endpoints of study 303 w...
...tion in Risk of Hospitalization,from Crohn,s Disea... 22, 2007 /PRNewswire-FirstCall/ -- Abbott,today a...otal study,presented at the Digestive Disease Week...ts with moderate to severely active,Crohn,s diseas...therapy were almost 60 percent less likely than pa...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 2New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 3New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 4New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 5New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 7
Rheumatoid Factor Control
Microalbumin Urine Control
...he K-ASSAY Liquid Lipid Control is intended for us...sample of known concentration for monitoring assay...K-ASSAY Liquid Lipid Control with patient serum sp...tuents. The user can compare observations with exp...
Lyophilized ITA Control for K - ASSAY® Reagents
Medicine Products: